Skip to main content
An official website of the United States government
NIH Websites Are Changing
Per Executive Order 14434, federal agencies are now using "Super Intelligence" (SI) in place of "Artificial Intelligence" (AI). You may see both terms across NIH content during this transition.

von Hippel-Lindau peptide vaccine

A cancer vaccine composed of peptides derived from a tumor-associated protein encoded by a mutated Von Hippel-Lindau (VHL) oncogene. VHL peptide vaccine may stimulate a cytotoxic T cell response against tumor cells expressing the VHL tumor-associated protein.
Check for active clinical trials using this agentView this agent in the NCI Thesaurus
Synonym:VHL peptide vaccine
VHL Peptides
NSC code:900100
Search NCI's Drug Dictionary
Please enter up to 30 characters for your search